Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 6
- >
Displaying 1-50 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Suurs F | Vries E.G.E. de, prof. dr. | Lub-de Hooge M.N., dr. | Rijksuniversiteit Groningen (RUG) | 2021 | Molecular imaging of immunotherapy biodistribution and the tumor immune environment | |||
(Pro)renin revisited: new insights from studies in mast cells | Krop M., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2009 | Cardiovascular disease; Pharmacology; Prorenin; | |||
A quest to optimize the clinical pharmacology of tuberculosis and human immunodeficiency virus drug treatment | Daskapan A., PhD | Werf T.S. van der, prof. dr. | Alffenaar J.W.C., prof. dr. | Stienstra Y., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Tuberculosis; Immunodeficiency virus drug treatment | |
Acute and chronic pain after cardiac surgery | Gulik L. van, PhD | Knibbe C.A.J., prof. dr. | Tibboel D., prof. dr. | Bruins P., dr. | Universiteit Leiden (UL) | 2014 | Acute pain; Intensive Care Unit; Chronic pain; Cardiac surgery; Pain management; | |
Adequate antimicrobial treatment in elderly patients | Haeseker M.B., PhD | Verbon A., prof. dr. | Bruggeman C.A.M.V.A., prof. dr. | Hoebe C.J.P.A., prof. dr. | Stolk L.M.L., dr | Universiteit Maastricht (UM) | 2015 | Antibiotics; Elderly; Drug dosing; |
ADHD medication use and long-term consequences | Ban E.F. van den, PhD | Egberts A.C.G., prof. dr. | Swaab-Barneveld J.T., prof. dr. | Heerdink E.R., dr. | Universiteit Utrecht (UU) | 2014 | ADHD medication use; Long-term consequences; | |
Adherence to antiretroviral combination therapy in children : what a difference half a day makes... | Piana C., PhD | Danhof M., prof. dr. | Della Pasqua O.E., dr. | Universiteit Leiden (UL) | 2013 | Paediatrics; Antiretroviral combination therapy; Compliance; Antiretroviral drugs; Paediatric populations; Drug combinations; Model-based; Covariate analysis; Predictive pharmacokinetic models; Clinical trial simulations; Adherence; Forgiveness of non-adherence; | ||
Advanced vascular imaging : technical and clinical applications in type 2 diabetes | Boer S.A. de, PhD | Kamphuisen T.P.W., prof. dr. | Slart R.H.J.A., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2017 | Pharmacology; advanced vascular imaging; Diabetes mellitus; | ||
Adverse drug reactions in individual patient care : documentation and prevention of represcription | Linden C.M.J. van der, PhD | Korsten H.H.M., prof. dr. | Egberts A.C.G., prof. dr. | Jansen P.A.F., dr. | Grouls R.J.E., dr. | Technische Universiteit Eindhoven (TUE) | 2013 | Adverse drug reactions; Patient care; Prevention; Represcription; |
Adverse drug reactions of angiotensin-converting enzyme inhibitors : towards precicion medicine | Mahmoud Pour S.H., PhD | Boer A. de, prof. dr. | Asselbergs F.W., prof. dr. MD FES | Maitland-van der Zee A.H., prof. dr. | Universiteit Utrecht (UU) | 2016 | Adverse drug reaction; Pharmacoepidemiology; Pharmacovigilance; ACE Inhibitors | |
Albuminuria: more than a renal risk marker? | Belt S.M. van den, PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Albuminuria; Risk markers; | ||
An orchestra in need of a conductor challenges and opportunities in multi-infusion therapy | Doesburg F | Touw D.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2021 | multi-infusion therapy | |||
Angiogenic imbalance in preeclampsia: pathogenic, diagnostic and prognostic implications | Saleh L., PhD | Danser A.H.J., prof. dr. | Steegers E.A.P., prof. dr. | Meiracker A.H. van den, dr. | Visser W, Dr. | Erasmus Universiteit Rotterdam (EUR) | 2018 | Pre-eclampsia; Pregnant women; Pregnancy; Renin-angiotensin system; Treatment options; |
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factors | Batenburg W.W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Anti sense and sensibility : renal and skin effects of (antisense) oligonucleotides | Meer, van L., Dr. | Cohen A.F., prof. dr. | Burggraaf J., prof. dr. | Moerland M., dr. | Universiteit Leiden (UL) | 2017 | Oligonucleotide Antisense Type 2 diabetes mellitus Clinical trial Phase2study | |
Antifungal pharmacokinetics in the era of the obesity pandemic | Wasmann R.E., PhD | Burger D.M., prof. dr. | Knibbe C.A.J., prof. dr. | Brüggemann R.J.M., PhD | Radboud Universiteit (RU) | 2019 | Antifungal drugs; Clinical pharmacology; Morbid obesity; Micafungin; Anidulafungin; Posaconazole; Liposomal amphotericinB; | |
Antiplatelet drugs for secondary prevention of cardiovascular diseases : drug utilization, effectiveness, and safety | Noorsyahdy A.Y., MD PhD | Boer A. de, prof. dr. | Klungel O.H., prof. dr. | Deneer V.H.M., dr. | Universiteit Utrecht (UU) | 2017 | Antiplatelet drugs; Secondary prevention; Myocardial infarction; Ischemic stroke; Cardiac arrest; Pharmacogenetics; | |
Antipsychotic induced parkinsonism: assessment, causes and consequences | Knol W., PhD | Egberts A.C.G., prof. dr. | Schobben A.F.A.M., prof. dr. | Marum R.J. van, prof. dr. | Jansen P.A.F., dr. | Universiteit Utrecht (UU) | 2011 | Antipsychotics; elderly; parkinsonism; pharmacokinetics; pharmacodynamics; pharmacogenetics; assessment |
Antipsychotics, delirium and glucose in older patients | Keulen K. van, PhD | Egberts A.C.G., prof. dr. | Knol W., PhD | Heerdink E.R., dr. | Universiteit Utrecht (UU) | 2018 | Antipsychotics; Older patients; Delirium; Hypoglycemia; Hyperglycemia; Incapacitated patients; Glucose variability; | |
Aortic pathology and the role of the renin-angiotensin system | Molzer E., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | |||
Appropriate prescribing for older people | Drenth-van Maanen A.C., PhD | Egberts A.C.G., prof. dr. | Jansen P.A.F., dr. | Marum R.J. van, prof. dr. | Universiteit Utrecht (UU) | 2013 | Prescribing; Elderly; Polypharmacy; Transitional pharmaceutical care; | |
Assessing long-term and rare adverse effects of medicines | Duijnhoven R.G., PhD | Boer A. de, prof. dr. | Hoes A.W., prof. dr. | Bruin M.L. de, prof. dr. | Straus S.M.J.M., dr. | Universiteit Utrecht (UU) | 2016 | Adverse effects; Case-control studies; Clinical trials; Cohort studies; Long-term consequences; Medicines; Regulatory; |
Assessing the impact of gout:validating and understanding outcomes | Spaetgens B.P.A., dr | Boonen A.E.R.C.H., prof. dr. | Vries F. de, prof. dr. | Universiteit Maastricht (UM) | 2017 | |||
Assessment of ischaemia and reperfusion injury | Wouters C.W., PhD | Rongen G.A., prof. dr. | Oyen W.J.G., prof. dr. | Radboud Universiteit (RU) | 2013 | Ischemia/reperfusion injury; adenosine; atorvastatin; forearm; | ||
Benefits and risks for the individual : anticoagulation for patients with atrial fibrillation | Ham H.A. van den, PhD | Leufkens H.G.M., prof. dr. | Klungel O.H., prof. dr. | Staa T.J. van, prof. dr. | Universiteit Utrecht (UU) | 2016 | Benefit-risk balance; Atrial fibrillation; Oral anticoagulants; Observational studies; Individuals; | |
Better prediction of drug response in diabetic kidney disease | Idzerda N.M.A. | Lambers Heerspink H.J., prof. dr. | Zeeuw D. de, prof. dr. | Pena M.J., PhD | Rijksuniversiteit Groningen (RUG) | 2020 | Diabetic kidney disease; Drug response; | |
Bioanalysis and biotransformation of tyrosine kinase inhibitors in oncology | Rood J.J.M., PhD | Beijnen J.H., prof. dr. | Sparidans R.W., dr. | Universiteit Utrecht (UU) | 2019 | |||
Bioanalysis and clinical pharmacology of tamoxifen in breast cancer | Jager N.G.L., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Rosing H., dr. | Universiteit Utrecht (UU) | 2014 | Cancer; Clinical pharmacology; | |
Biomarkers as assessment of drug efficacy in cardiovascular disease | Smink P.A., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Bakker S.J.L., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2013 | cardiovascular disease biomarkers drug efficacy | |
Biomarkers in real-life COPD management | Oshagbemi O.A., PhD | Wouters E.F.M., prof. dr. | Vries F. de, prof. dr. | Franssen F.M.E., dr. | Universiteit Maastricht (UM) | 2019 | ||
Biomedical engineering for breathomics: towards clinical application in respitaroty diseases biomarker, instruments and Technology Readiness Levels | Brinkman P., PhD | Sterk P.J., prof. dr. | Maitland-van der Zee A.H., prof. dr. | Jongh F.H.C. de, dr.ir. | Universiteit van Amsterdam (UvA) | 2019 | ||
Building a clinical pharmacology framework for the safe and effective use of antifungal agents | Lempers VJC | Burger D.M., prof. dr. | Brüggemann R.J.M., PhD | Aarnoutse R.E., dr. | Radboud Universiteit (RU) | 2016 | Antifungal drugs; Clinical pharmacology; | |
Cardiac aldosterone: origin and effects | Chai W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Cardiovascular molecular imaging | Haas H.J. de, PhD | Dierckx R.A.J.O., prof. dr. | Slart R.H.J.A., prof. dr. | Boersma H.H., dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Pharmacology; Cardiovascular molecular imaging | |
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approach | Kappers M.H.W., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Cancer; Pharmacology; Antihypertensive drugs; | |||
Carotid artery contrast enhanced ultrasound | Kate G.L. ten, PhD | Sijbrands E.J.G., prof. dr. | Danser A.H.J., prof. dr. | Schinkel A.F.L., Dr. | Erasmus Universiteit Rotterdam (EUR) | 2014 | Cardiovascular disease; Vascular reactivity; | |
Challenges and opportunities in pharmacogenomics: studies in cardiovascular disease and asthma | Leusink M., PhD | Boer A. de, prof. dr. | Bakker P.I.W. de, prof. dr. | Maitland-van der Zee A.H., prof. dr. | Onland-Moret N.C., dr. | Universiteit Utrecht (UU) | 2015 | Pharmacogenomics; Cardiovascular disease; Asthma; Genomics; Genetics; Pharmacology; Statins; Inhaled corticosteroids; Cholesterol; |
Challenges in the clinical development of orphan drugs | Kreeftmeijer-Vegter A.R., PhD | Boer A. de, prof. dr. | Vries P.J. de, dr. | Universiteit Utrecht (UU) | 2015 | Orphan drugs; Clinical development; Paediatric formulation; Pharmacokinetics; Efficacy; Safety; Regulatory; | ||
Challenges in using cardiovascular medications in Sub-Saharan Africa | Berhe D.F., PhD | Haaijer-Ruskamp F.M., prof. dr. | Taxis K., prof. dr. | Mol P.G.M., dr. | Rijksuniversiteit Groningen (RUG) | 2017 | Pharmacology; Medication use; Cardiovascular disease; | |
Challenging the cholinergic system: ageing, cognition & inflammation | Alvarez-Jimenez R., PhD | Gerven J.M.A. van, prof. dr. | Cohen A.F., prof. dr. | Groeneveld G.J., prof. dr. | Universiteit Leiden (UL) | 2017 | Neuropsychopharmacology Clinical Pharmacology Trials Cognition Dementia Cholinergis system Drug development | |
Characterization and re-evaluation of experimental pain models in healthy subjects | Siebenga P.S | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2020 | Analgesics Human evoked pain models Neuropathic pain Nociceptive pain Pharmacodynamics Phase-1 clinical triala | |||
Characterization of vascular 5-hydroxytryptamine, adrenergic and CGRP receptors in relation to migraine | Mehrotra S., dr. | Saxena P.R., prof. dr. | Danser A.H.J., prof. dr. | Maassen van den Brink A., dr. | Erasmus Universiteit Rotterdam (EUR) | 2006 | Cardiovascular disease; Pharmacology; | |
Child friendly medicines : availability, pharmaceutical design, usability and patient outcomes | Riet-Nales D.A. van, PhD | Schobben A.F.A.M., prof. dr. | Egberts A.C.G., prof. dr. | Rademaker C.M.A., dr. | Universiteit Utrecht (UU) | 2014 | Paediatrics; Drug compounding; Consumer satisfaction; Formulation; Mini tablet; Splitter; Usability; EMA; | |
Clinical decision support in community pharmacy | Heringa M., PhD | Bouma H.R., PhD | Smet P.A.G.M. de, prof. dr. | Floor-Schreudering A., PhD PharmD | Universiteit Utrecht (UU) | 2017 | Patient safety; Clinical decision support system; Community pharmacy; Drug therapy; | |
Clinical manifestations of sex hormonal influences in migraine | Casteren D.S. van, PhD | Danser A.H.J., prof. dr. | Terwindt G.M., prof. dr. | Maassen van den Brink A., dr. | Universiteit Leiden (UL) | 2021 | Migraine; Clinical pharmacology; Treatment; Endocrinology; Pharmacology; | |
Clinical pharmacological aspects of mitochondrial function in muscle | Diemen M.P.J. van, PhD | Cohen A.F., prof. dr. | Nelissen R.G.H.H., prof. dr. | Groeneveld G.J., prof. dr. | Universiteit Leiden (UL) | 2021 | Clinical pharmacology; Huntington's disease; Mitochondrial function; Magnetic Resonance Spectroscopy; Sarcopenia; Phosphocreatine recovery rate; Knee; Total knee arthroplasty; Wearables; Peripheral blood mononuclear cells; Protoporphorin IX Triple State Lifetime techn; | |
Clinical pharmacological studies in tuberculosis patients | Semvua H.H., PhD | Burger D.M., prof. dr. | Aarnoutse R.E., dr. | Boeree M.J., dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; Pharmacokinetics; Tuberculosis | |
Clinical pharmacology and bioanalysis of antileishmanial drugs : Towards improved treatment strategies for leishmaniasis | Kip A.E., PhD | Beijnen J.H., prof. dr. | Schellens J.H.M., prof. dr. | Dorlo T.P.C., dr. | Universiteit Utrecht (UU) | 2017 | Leishmaniasis; Clinical pharmacology; Bioanalysis; Pharmacokinetics; Pharmacodynamics; Miltefosine; Amphotericin B; Neopterin; | |
Clinical pharmacology and therapeutic drug monitoring of first-line anti-tuberculosis drugs | Sturkenboom M.G.G., PhD | Kosterink J.G.W., prof. dr. | Werf T.S. van der, prof. dr. | Uges D.R.A., prof. dr. | Alffenaar J.W.C., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Tuberculosis; Therapeutic drug monitoring; |
Clinical pharmacology and therapeutic drug monitoring of voriconazole | Veringa A., PhD | Alffenaar J.W.C., prof. dr. | Kosterink J.G.W., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2019 | drug monitoring; voriconazole |
Go to page:
- of 6
- >